HLA-B27

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search

WikiDoc Resources for

HLA-B27

Articles

Most recent articles on HLA-B27

Most cited articles on HLA-B27

Review articles on HLA-B27

Articles on HLA-B27 in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on HLA-B27

Images of HLA-B27

Photos of HLA-B27

Podcasts & MP3s on HLA-B27

Videos on HLA-B27

Evidence Based Medicine

Cochrane Collaboration on HLA-B27

Bandolier on HLA-B27

TRIP on HLA-B27

Clinical Trials

Ongoing Trials on HLA-B27 at Clinical Trials.gov

Trial results on HLA-B27

Clinical Trials on HLA-B27 at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on HLA-B27

NICE Guidance on HLA-B27

NHS PRODIGY Guidance

FDA on HLA-B27

CDC on HLA-B27

Books

Books on HLA-B27

News

HLA-B27 in the news

Be alerted to news on HLA-B27

News trends on HLA-B27

Commentary

Blogs on HLA-B27

Definitions

Definitions of HLA-B27

Patient Resources / Community

Patient resources on HLA-B27

Discussion groups on HLA-B27

Patient Handouts on HLA-B27

Directions to Hospitals Treating HLA-B27

Risk calculators and risk factors for HLA-B27

Healthcare Provider Resources

Symptoms of HLA-B27

Causes & Risk Factors for HLA-B27

Diagnostic studies for HLA-B27

Treatment of HLA-B27

Continuing Medical Education (CME)

CME Programs on HLA-B27

International

HLA-B27 en Espanol

HLA-B27 en Francais

Business

HLA-B27 in the Marketplace

Patents on HLA-B27

Experimental / Informatics

List of terms related to HLA-B27

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Human Leukocyte Antigen B*27 (subtypes B*2701-2724) is a class I surface antigen encoded by the B locus in the major histocompatibility complex (MHC) on chromosome 6 and presents microbial antigens to T-cells. HLA-B27 strongly associated with a certain set of autoimmune diseases referred to as the "seronegative spondyloarthropathies". In the general population, about 8% Caucasian, 4% African, 2-9% Chinese, and 0.1-0.5% Japanese have the HLA-B27 antigen. In Northern Scandinavia (Lapland), 24% of people are HLA-B27 positive while 1.8% have ankylosing spondylitis (AS).

Mystery

The relationship between HLA-B27 and many diseases has not yet been fully elucidated. Though it is associated with a wide range of pathology, it does not appear to be the sole mediator in development of disease. For example, while nearly all people with ankylosing spondylitis (AS) are HLA-B27 positive, only a fraction of people with HLA-B27 ever develop AS. This raises two important questions: why don't all HLA-B27 positive people develop AS, and why do some (although rarely) people who are HLA-B27 negative develop it? The literature is inconclusive, though several theories have been suggested and research continues.

Associated pathology

In addition to its connection with AS, HLA-B27 is implicated in Reiter's syndrome, certain eye disorders such as acute anterior uveitis and iritis, psoriatic arthritis and Crohn's disease. Reiter's syndrome then again, is statistically associated with AS.

See also

External links

de:HLA-B27



WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch

Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

In other languages